血栓闭塞性脉管炎是涉及多种超敏反应的自身免疫性疾病
Thromboangiitis Obliterans Is an Autoimmune Disease Involving Multiple Hy-persensitivity Types
摘要: 目的:本研究是基于我们早期研究报告显示的血栓闭塞性脉管炎(TAO, Buger’ Disease)可能是涉及到超敏反应III和lV的自身免疫性疾病的进一步研究。方法:测定28例TAO患者的体液免疫(IgE);采用三种免疫标记技术同步探测28例TAO血清中抗血管自身抗体和18例TAO病变血管上的抗原抗体复合物等,以确保结果的可靠性。结果:发现TAO病人血清中IgE显著升高(P < 0.01);三种免疫标记技术均发现血清中有高达86%的抗血管自身抗体(P < 0.001)和在血管壁全层有抗原抗体复合物沉积及自身抗体直接结合于血管胶原。结论:进一步证实TAO是一种自身免疫性疾病,且发现涉及多种超敏反应。其发病机制主要是III型超敏,除了与IV型有关外,还有II型的参与。IgE明显升高提示TAO患者或有被致敏原致敏的I型超敏反应的存在。
Abstract: Object: Our early study about thromboangiitis obliterans (TAO, Buger’s Disease) has been reported that it may be an autoimmune disease involving hypersensitivity Type III & Type IV. In this study, we further explored the immune pathogenesis of thromboangiitis obliterans based on initial re-search. Method: We detected humoral immunity (IgE) in 28 cases, antigen-antibody complex de-positing on the vessel wall in 18 cases, and anti-vessel antibodies in 28 cases using three kinds of immune-labeling technique to confirm the new findings. Result: IgE levels were significantly high (P < 0.01). As high as 86% of anti-vessel antibodies in serum were found (P < 0.001), and the au-to-antibodies against the vessel were combined directly with vascular collagen. Antigen-antibody complexes were deposited on the vascular wall. Conclusion: These findings further confirm throm-boangiitis obliterans is an autoimmune disease and involving multiple hypersensitivity reactions. This is mainly Type III hypersensitivity and type II in addition to type IV. The elevated IgE suggests that TAO may a type I hypersensitivity involved.
文章引用:郑萍, 王万超. 血栓闭塞性脉管炎是涉及多种超敏反应的自身免疫性疾病[J]. 临床医学进展, 2023, 13(6): 10050-10057. https://doi.org/10.12677/ACM.2023.1361405

参考文献

[1] Mills Sr, J.L. (2003) Buerger’s Disease in the 21st Century: Diagnosis, Clinical Features and Therapy. Seminars in Vas-cular Surgery, 16, 179-189. [Google Scholar] [CrossRef
[2] 王嘉桔, 赵文光, 孙思翘, 等. 血栓闭塞性脉管炎的发病变迁(百年回顾之一) [J]. 中国血管外科杂志(电子版), 2009, 1(1): 9-12.
[3] 郑萍. 血栓闭塞性脉管炎的病因和发病机理[J]. 北方医学, 1983(5): 13-15.
[4] 郑萍, 傅培彬, 王万超, 等. 血栓闭塞性脉管炎(TAO)的免疫功能状态研究[J]. 上海免疫学杂志, 1985(3): 146-151.
[5] 王万超, 谢雅莉, 李萱茂, 等. 直接免疫荧光技术对人体T淋巴细胞表面免疫球蛋白检测的探讨及应用[J]. 中华医学检验杂志, 1982, 5(2): 74-76.
[6] 马宝骊, 王一飞, 王万超, 等. 医学免疫学[M]. 第1版. 上海: 上海同济大学出版社, 1987: 164-1718.
[7] Pokorny, J. and Jezkova, Z. (1962) Significance of Immunological Studies in Peripheral Obliterating Vascular Diseases. Circulation Research, 11, 961-965. [Google Scholar] [CrossRef
[8] 王嘉桔, 赵文光, 郑萍, 等. 对血栓闭塞性脉管炎的新认识[J]. 吉林医学, 1886, 7(5): 53.
[9] 杨博华, 张述刚, 李令根, 等. 关于血栓闭塞性脉管炎病人体液免疫功能的研究[J]. 中医药信息, 1987(5): 34-36.
[10] Eichhorn, J., Sina, D., Lindschau, C., et al. (1995) Antiendotheluial Cell Antibodies in Thromboangiitis Obliterans. The American Journal of the Medical Sciences, 315, 17-23.
[11] Halacheva, K.S., Manolova, I.M., Petkov, D.P., et al. (1998) Study of An-ti-Neutrophil Disease. Scandinavian Journal of Immunology, 48, 544-550.
[12] 王俊英, 蒋米尔, 薛莲. 血栓闭塞性脉管炎患者抗磷脂蛋白抗体检测及意义[J]. 上海医学, 1997(5): 280-282.
[13] de Godoy, J.M.P. and Braile, D.M. (2009) Burger’s Disease and Anticardiolipin Antibodies. Journal of Cardiovascular Medicine, 10, 792-794. [Google Scholar] [CrossRef
[14] Klein-Weigel, P.F., Bimmler, M., Hempel, P., et al. (2014) G-Protin Coupled Recepter Auto-Antiboties in Thromboangiitis Obliterans (Buerger’s) and Their Removal by Immuno-adsorption. Vasa, 43, 347-352. [Google Scholar] [CrossRef] [PubMed]
[15] Dellalibera-Joviliano, R., Joviliano, E.E., Silva, J.S. and Evora, P.R.B. (2012) Activation of Cytokines Corroborate with Development of Inflammation and Autoimmunity in Thrombo-angiitis Obliterans Patients. Clinical and Experimental Immunology, 170, 28-35. [Google Scholar] [CrossRef] [PubMed]
[16] Halacheva, K., Gulubova, M.V., Manolova, I. and Petkov, D. (2002) Expression of ICAM-1, VCAM-1, E-Selectin and TNF-α on the Endothelium of Femoral and Iliac Arteries in Thromboangiitis Obliterans. Acta Histochemica, 104, 177-184. [Google Scholar] [CrossRef] [PubMed]
[17] 伏祥茂, 景在平, 郭峰. 血栓闭塞性脉管炎患者红细胞免疫功能及调节因子的研究[J]. 上海医学, 1997(7): 403-404.
[18] 郭轶, 代远斌. 血栓闭塞性脉管炎患者血管壁的免疫病理学研究[J]. 重庆医科大学学报, 2009, 34(12): 1683-1685.
[19] Baumann, G., Stangl, V., Klein-Weigel, P., et al. (2011) Successful Treatment of Thromboangiitis Obliterans (Burger’ s Disease) with Immunoadsorption: Results of a Pilot Study. Clinical Research in Cardiology, 100, 683-690. [Google Scholar] [CrossRef] [PubMed]
[20] Klein-Weigel, P., Volz, T.S., Gutsche-Petrak, B., et al. (2016) Immunoadsorption in Buerger’s Disease (Thromboangiitis Obliterans): A Promising Therapeutic Option: Result of Con-secutive Patient COHORT Treated in Clinical Routine Care. Lupus Open Access, 1, Article 114. [Google Scholar] [CrossRef
[21] 尹悦, 李莉. IgE与自身免疫性疾病关系的研究进展[J]. 中华检验医学杂志, 2018, 41(3): 242-245.
[22] Kimura, A., Kohayashi, Y., et al. (1998) MICA Gene Polymorphism in Takayasu’s Arteritis and Buerger’s Disease. International Journal of Cardiology, 66, S107-S113. [Google Scholar] [CrossRef
[23] Fakour, F. and Fazeli, B. (2019) Visceral Bed Involvement in Thromboangiitis Obliterans: A Systematic Review. Vascular Health and Risk Management, 15, 317-353. [Google Scholar] [CrossRef
[24] 上海第二医学院附属瑞金医院中西医结合脉管炎小组, 上海第二医学院附属瑞金医院内科. 血栓闭塞性脉管炎合并心肌梗塞三例报告[J]. 心脏血管疾病, 1978, 6(1): 19-21.
[25] Papa, M., Bass, A., Adar, R., et al. (1992) Autoimmune Mechanisms in Thromboangiitis Obliterans (Buerger’s Disease): The Role of Tabacco Antigen and the Majio Histocompatibility Complex. Surgery, 111, 527-531.
[26] 孙凯, 冯琦, 窦科峰. 性激素免疫调节效应与疾病发生的关系[J]. 中华预防医学杂志, 2002, 36(6): 421-423.
[27] 郑萍, 陈赛娟, 邵慧珍. 血栓闭塞性脉管炎血液高凝狀态的研究[J]. 中华医学杂志(英文版), 1989, 102(1): 67-71.